期刊文献+

15%甲维·吡虫啉悬浮剂的研制 被引量:2

Preparation of 15% Suspension Concentrate Formulation of Emamectin Benzoate and Imidacloprid
下载PDF
导出
摘要 通过对润湿分散剂、防冻剂、增稠剂的筛选,确定了15%甲维.吡虫啉悬浮剂优惠配方:78.2%甲维盐原药6.5%,95.6%吡虫啉原药10.6%,润湿分散剂GY-SC85 3.0%,防冻剂尿素4.0%,增稠剂黄原胶0.2%、硅酸镁铝0.5%,消泡剂GY-X60 0.2%,水75.0%。该优惠配方制备的悬浮剂低温和热贮后物理化学性质稳定。 The optimum 15% suspension concentrate formulation of emamectin benzoate and imidacloprid was developed by screening wetting and dispersing agents, anti - freezer, thickener, which consists of 78.2% emamectin benzoate (6.5%), 95.6% imidacloprid ( 10.6% ), wetting dispersant GY - SC85 (3.0%), anti - freezer urea (4.0%), thickener (0.2% xanthan gum and 0.5% magnesium aluminum silicates), defoamer GY - X60 (0.2%), and water (75.0%). The physical and chemical properties of the formulation did not change significantly after it was stored under -1℃and 54℃ conditions for 14 days.
出处 《山东化工》 CAS 2012年第11期8-11,共4页 Shandong Chemical Industry
基金 "十二五"国家科技支撑计划课题(2011BAE06B06-1) "十二五"农村领域国家科技计划课题(2011AA10A201)
关键词 甲维盐 吡虫啉 悬浮剂 emamectin benzoate imidacloprid suspension concentrate
  • 相关文献

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部